Source: Pharamceutical Technology

Amneal: Amneal and Shilpa introduce Boruzu in US for cancer treatment

Amneal Pharmaceuticals, along with Shilpa Medicare, has launched the new presentation of bortezomib, Boruzu.

Read full article »
Annual Revenue
$1.0-5.0B
Employees
5.0-10K
Chintu Patel's photo - Co-CEO of Amneal

Co-CEO

Chintu Patel

CEO Approval Rating

74/100

Read more